SBC Medical Group Holdings Incorporated
NASDAQ:SBC · NASDAQ Global Market
+$0.04 today
Vol 0.08M · Avg 0.12M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:SBC · Revenue to Net Income
Key Ratios
Analysis
$169.3M of revenue converted into $40.8M of net income for the selected period. Gross margin is 70.3% and net margin is 24.4%, showing how much revenue survives after costs and taxes. EPS is $0.39, tying the income statement back to per-share earnings.
Income Statement
Annual data · 4 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $173.6M -15.5% | $205.4M +6.1% | $193.5M +11.1% | $174.2M | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $46.3M -6.2% | $49.4M -12.2% | $56.2M -5.2% | $59.3M | $344.8M | $725.6M | $804.0M |
| Gross Profit | $127.3M -18.4% | $156.1M +13.7% | $137.3M +19.6% | $114.8M | $10.3B | $8.9B | $7.6B |
| Gross Margin | 73.3% -2.7pp | 76.0% +5.0pp | 70.9% +5.0pp | 65.9% | 45.5% | 9.8% | 28.9% |
| Research & Development | $0 | $0 | $0 | $0 | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | $59.8M -14.7% | $70.1M +5.8% | $66.2M -29.1% | $93.5M | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $59.8M -30.3% | $85.7M +28.7% | $66.6M -29.6% | $94.7M | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $2.7M -29.3% | $3.8M -69.0% | $12.2M +106.5% | $5.9M | $1.2B | $374.2M | $1.2B |
| EBITDA | $84.9M +9.9% | $77.3M -10.0% | $85.9M +189.7% | $29.6M | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 48.9% +11.3pp | 37.6% -6.7pp | 44.4% +27.3pp | 17.0% | 10.0% | 5.6% | 46.3% |
| Operating Income | $67.5M -4.0% | $70.3M -0.5% | $70.7M +251.2% | $20.1M | $10.6B | $12.3B | $14.0B |
| Operating Margin | 38.9% +4.6pp | 34.2% -2.3pp | 36.5% +25.0pp | 11.6% | 18.7% | 16.6% | 24.1% |
| Interest Income | $198.3K +894.4% | $19.9K -77.0% | $86.7K -81.6% | $472.4K | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $160.6K +467.4% | $28.3K -37.5% | $45.3K +44.1% | $31.4K | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | $14.6M +362.5% | $3.2M +8.0% | $2.9M -18.0% | $3.6M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $82.1M +11.7% | $73.5M -0.2% | $73.6M +210.8% | $23.7M | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 47.3% +11.5pp | 35.8% -2.3pp | 38.0% +24.4pp | 13.6% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $31.0M +15.9% | $26.8M -23.6% | $35.0M +93.2% | $18.1M | $666.8M | $1.3B | -$1.6B |
| Net Income | $51.0M +9.4% | $46.6M +18.4% | $39.4M +523.4% | $6.3M | $5.0B | $4.9B | $4.8B |
| Net Margin | 29.4% +6.7pp | 22.7% +2.4pp | 20.3% +16.7pp | 3.6% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $1 +4.2% | $0 +14.3% | $0 +569.9% | $0 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $1 +4.2% | $0 +14.3% | $0 +569.9% | $0 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $103.0M +6.7% | $96.6M +2.5% | $94.2M +525.2% | $15.1M | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $103.0M +6.7% | $96.6M +2.5% | $94.2M +525.2% | $15.1M | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Spire Global, Inc.
NYSE:SPIR
$582.08M
Concrete Pumping Holdings, Inc.
NASDAQ:BBCP
$552.82M
Luxfer Holdings PLC
NYSE:LXFR
$509.61M
The Manitowoc Company, Inc.
NYSE:MTW
$478.32M
Pangaea Logistics Solutions, Ltd.
NASDAQ:PANL
$477.20M
Wabash National Corporation
NYSE:WNC
$461.85M
ACCO Brands Corporation
NYSE:ACCO
$359.28M
KNOT Offshore Partners LP
NYSE:KNOP
$343.34M
flyExclusive, Inc.
AMEX:FLYX
$177.92M
Rich Sparkle Holdings Limited Ordinary Shares
NASDAQ:ANPA
$57.50M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does SBC generate?
SBC Medical Group Holdings Incorporated (SBC) reported $173.61M of revenue in fiscal 2025.
Is SBC profitable?
SBC Medical Group Holdings Incorporated (SBC) reported $50.99M of net income, with a net margin of 29.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.